2024

Time to disability milestones and annualized relapse rates in NMOSD and MOGAD
Duchow A, Bellmann-Strobl J, Friede T, Aktas O, Angstwurm K, Ayzenberg I, Berthele A, Dawin E, Engels D, Fischer K, Flaskamp M, Giglhuber K, Grothe M, Havla J, Hümmert M, Jarius S, Kaste M, Kern P, Kleiter I, Klotz L, Korporal-Kuhnke M, Kraemer M, Krumbholz M, Kümpfel T, Lohmann L, Ringelstein M, Rommer P, Schindler P, Schubert C, Schwake C, Senel M, Bergh F, Tkachenko D, Tumami H, Trebst C, Vardakas I, Walter A, Warnke C, Weber M, Wickel J, Wildemann B, Winkelmann A, Paul F, Stellmann J, Häußler V
ANN NEUROL. 2024;95(4):720-732.

Fatigue and associated factors in myasthenia gravis: a nationwide registry study
Funke M, Eveslage M, Zschüntzsch J, Hagenacker T, Ruck T, Schubert C, Schroeter M, Meisel A, Wiendl H, Hoffmann S, Lünemann J
J NEUROL. 2024;271(8):5665-5670.

Treatment of Cerebral Histiocytosis With Low Dose of Cobimetinib: A Report of 2 Cases
Schubert C, Schiffmann I, Farschtschi S, Emile J, Friese M
NEUROL-NEUROIMMUNOL. 2024;11(3):e200233.

2023

Postpartum relapse risk in multiple sclerosis: a systematic review and meta-analysis
Schubert C, Steinberg L, Peper J, Ramien C, Hellwig K, Köpke S, Solari A, Giordano A, Gold S, Friede T, Heesen C, Rahn A
J NEUROL NEUROSUR PS. 2023;94(9):718-725.

A2A adenosine receptor-driven cAMP signaling in olfactory bulb astrocytes is unaffected in experimental autoimmune encephalomyelitis
Wendlandt M, Kürten A, Beiersdorfer A, Schubert C, Samad-Yazdtchi K, Sauer J, Pinto M, Schulz K, Friese M, Gee C, Hirnet D, Lohr C
FRONT IMMUNOL. 2023;14:1-10.

2022

Simulation-based training improves process times in acute stroke care (STREAM)
Bohmann F, Gruber K, Kurka N, Willems L, Herrmann E, du Mesnil de Rochemont R, Scholz P, Rai H, Zickler P, Ertl M, Berlis A, Poli S, Mengel A, Ringleb P, Nagel S, Pfaff J, Wollenweber F, Kellert L, Herzberg M, Koehler L, Haeusler K, Alegiani A, Schubert C, Brekenfeld C, Doppler C, Onur Ö, Kabbasch C, Manser T, Steinmetz H, Pfeilschifter W
EUR J NEUROL. 2022;29(1):138-148.

Neuronal Adenosine A1 Receptor is Critical for Olfactory Function but Unable to Attenuate Olfactory Dysfunction in Neuroinflammation
Schubert C, Schulz K, Träger S, Plath A, Omriouate A, Rosenkranz S, Morellini F, Friese M, Hirnet D
FRONT CELL NEUROSCI. 2022;16:.

2021

Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis
Kaufmann M, Evans H, Schaupp A, Engler J, Kaur G, Willing A, Kursawe N, Schubert C, Attfield K, Fugger L, Friese M
MED-CAMBRIDGE. 2021;2(3):296-312.e8.

Enhancing mitochondrial activity in neurons protects against neurodegeneration in a mouse model of multiple sclerosis
Rosenkranz S, Shaposhnykov A, Träger S, Engler J, Witte M, Roth V, Vieira V, Paauw N, Bauer S, Schwencke-Westphal C, Schubert C, Bal L, Schattling B, Pless O, van Horssen J, Freichel M, Friese M
ELIFE. 2021;10:e61798.

2019

Simulation-Based Training of the Rapid Evaluation and Management of Acute Stroke (STREAM)-A Prospective Single-Arm Multicenter Trial
Bohmann F, Kurka N, du Mesnil de Rochemont R, Gruber K, Guenther J, Rostek P, Rai H, Zickler P, Ertl M, Berlis A, Poli S, Mengel A, Ringleb P, Nagel S, Pfaff J, Wollenweber F, Kellert L, Herzberg M, Koehler L, Haeusler K, Alegiani A, Schubert C, Brekenfeld C, Doppler C, Onur O, Kabbasch C, Manser T, Pfeilschifter W
FRONT NEUROL. 2019;10:969.

Direct current stimulation-induced synaptic plasticity in the sensorimotor cortex: structure follows function
Gellner A, Reis J, Holtick C, Schubert C, Fritsch B
BRAIN STIMUL. 2019;13(1):80-88.

Letzte Aktualisierung aus dem FIS: 29.11.2024 - 23:34 Uhr